Therapeutic Conflicts and Multimorbidity

NCT02928939 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1101

Last updated 2021-04-08

No results posted yet for this study

Summary

Clinical practice guidelines do not take into account multimorbidity and various potential therapeutic conflicts. Identifying and quantifying therapeutic conflicts is crucial in multimorbid patients having more than two acute or chronic diseases. Guidance should be available for frequent encountered situations, e.g. gastrointestinal bleeding or exacerbation of diabetes mellitus.

Conditions

  • Gastrointestinal Hemorrhage
  • Diabetes Complications
  • Multimorbidity

Interventions

OTHER

drug-drug or drug-disease interaction

Sponsors & Collaborators

  • University Hospital, Zürich

    collaborator OTHER
  • Center of Competence Multimorbidity, Zurich

    collaborator UNKNOWN
  • University of Zurich

    lead OTHER

Principal Investigators

  • Edouard Battegay, Prof. MD · University Hospital Zurich, Department of Internal Medicine

  • Klarissa Siebenhüner, MD · University Hospital Zurich, Department of Internal Medicine

  • Patrick Beeler, MD · University Hospital Zurich, Department of Internal Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2020-08-31
Completion
2021-04-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02928939 on ClinicalTrials.gov